Workflow
Inflammatory Eye Diseases
icon
Search documents
OKYO Pharma(OKYO) - Prospectus(update)
2023-02-22 14:19
(Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) As filed with the Securities and Exchange Commission on February 22, 2023. Registration Statement No. 333-268675 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 5 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OKYO Pharma Limited (Name, address, including zip code, and telephone number, including area code, of agent for service) Copi ...